Medicare Enrolled

Dr. Daniela Dicenso, D.O.

Endocrinology · Miami, FL
12515 SW 88TH ST, Miami, FL 33186
3056425366
Registered in NPPES since 2016
NPI: 1194173831 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dicenso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dicenso? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dicenso

Dr. Daniela Dicenso is an endocrinology specialist in Miami, FL, with 10 years of NPI registration.

Between the years covered by Open Payments, Dr. Dicenso received a total of $3,562 from 37 pharmaceutical and/or device companies across 149 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dicenso is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years of NPI registration $3,562 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 15646 Clear March 31, 2028 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$3,562
Total received (2018-2024)
Avg $594/year across 6 years
Top 48% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
149
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25
2023
$148
2022
$1,963
2021
$711
2019
$280
2018
$435

Payments by company (2024)

Lilly USA, LLC
$25
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Insulet Corporation
$548
Lilly USA, LLC
$428
Novo Nordisk Inc
$279
SANOFI-AVENTIS U.S. LLC
$212
Tandem Diabetes Care, Inc.
$208
Amgen Inc.
$190
MannKind Corporation
$146
Abbott Laboratories
$131
Mitsubishi Tanabe Pharma America, Inc.
$129
Amarin Pharma Inc.
$125
AstraZeneca Pharmaceuticals LP
$109
Astellas Pharma US Inc
$108
DEXCOM, INC.
$104
Novartis Pharmaceuticals Corporation
$103
Melinta Therapeutics, Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$81
Amneal Pharmaceuticals LLC
$73
Currax Pharmaceuticals LLC
$62
Bayer HealthCare Pharmaceuticals Inc.
$49
Zealand Pharma US, Inc.
$35
CeQur Corporation
$33
IBSA Pharma Inc.
$33
Ascensia Diabetes Care Us Inc.
$25
Ultragenyx Pharmaceutical Inc.
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Xeris Pharmaceuticals, Inc.
$23
LIFESCAN, INC.
$21
Corcept Therapeutics
$19
Dexcom, Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$18
EUSA Pharma (US) LLC
$18
Mannkind Corporation
$17
Collegium Pharmaceutical, Inc.
$16
Radius Health, Inc.
$16
PFIZER INC.
$15
VistaPharm, Inc.
$14
GENZYME CORPORATION
$11
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · Baxdela · CHANTIX · CONTRAVE · CRESEMBA · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · FARXIGA · FREESTYLE LIBRE 2 · GILENYA · GVOKE PFS · HUMULIN · JARDIANCE · Kerendia · Korlym · LEMTRADA · LEXISCAN · MOUNJARO · MYCAMINE · ONETOUCH VERIO REFLECT · Omnipod · Ozempic · RADICAVA · Radicava · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SYNJARDY · Sylvant · TOUJEO · TRULICITY · Thyquidity · Tirosint · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Wegovy · XIGDUO · XTAMPZA · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Miami?
Compare endocrinologists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
84
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
3.2 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dicenso is an endocrinology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Dicenso receive payments from pharmaceutical companies?
Yes. Dr. Dicenso received a total of $3,562 from 37 companies across 149 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Dicenso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Miami
Browse endocrinologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Insulet Corporation Payments to Doctors
See all physicians who received payments from Insulet Corporation.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →